Alan B. Sandler - Nov 7, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role: Chief Medical Officer
Signature: /s/ Reena R. Desai, as Attorney-In-Fact
Stock symbol: MRTX
Transactions as of: Nov 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 11/8/2022, 05:00 PM
Previous filing: Jun 27, 2022
Next filing: Aug 10, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRTX	Common Stock	Award	$0	+40K		$0.00	40K	Nov 7, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRTX	Stock Option (Right to buy)	Award	$0	+65K		$0.00	65K	Nov 7, 2022	Common Stock	65K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents a Restricted Stock Unit grant with a vesting period of 4 years that vests 25% annually from grant date and subject to the reporting persons continuously service to the issuer.
F2	25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.